Pharmacovigilance USA 2025

The 38th Pharmacovigilance USA 2025, taking place on May 7–8 at The Inn at Longwood Medical in Boston, Massachusetts, is one of the premier gatherings for professionals in drug safety, regulatory affairs, and risk management. Organized by Virtue Insight, this two-day conference will bring together industry leaders, regulators, and innovators to explore the evolving landscape of pharmacovigilance, including hot topics like AI integration, digital signal detection, and post-market surveillance.

Attendees can expect in-depth sessions, expert panel discussions, and practical case studies focusing on global PV regulations, inspection readiness, and emerging technologies. With a strong emphasis on compliance and innovation, this Boston-based event provides a vital networking platform for professionals aiming to stay ahead of regulatory expectations and technological disruption in pharmacovigilance.

Event Highlights:

• Dates: May 7–8, 2025

• Location: The Inn at Longwood Medical, Boston, Massachusetts

• Event Type: Conference

• Key Topics:

  • GenAI and AI integration in pharmacovigilance

  • Global PV compliance and inspection readiness

  • Digital tools and automation in case processing

• Featured Speakers from Big Pharma:

  • Khawdeja Bano – VP, Global Head of Device Quality, Roche – Genentech

  • Mariette Boerstroel-Streefland – SVP, Worldwide Patient Safety Officer, Bristol-Myers Squibb

  • Milind Sardesa – Senior Director, Safety Surveillance, Novo Nordisk